vTv Therapeutics adopts Third Amended and Restated By-Laws with new nomination and forum rules

vTv Therapeutics Inc.

Board approved the Third Amended and Restated By-Laws on October 1, 2026; changes cover director nominations, voting standards, forum selection and DGCL conformity.
Nominating stockholders must now deliver reasonable evidence of Rule 14a-19 compliance no later than five business days before the stockholder meeting.
Voting standard revised: in all matters other than director elections, the affirmative vote of a majority of voting power cast affirmatively or negatively is the act of stockholders.
Federal district courts designated as the exclusive forum for Securities Act of 1933 claims unless the Company consents in writing to an alternative forum.
Amended By-Laws attached as Exhibit 3.1; 8-K signed by President and CEO Paul J. Sekhri and dated October 6, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.